Natalia Jaworska1,2, Stephana J Moss3,4, Karla D Krewulak3,5, Zara Stelfox3, Daniel J Niven3,5,6,7, Zahinoor Ismail5,6,7,8,9, Lisa D Burry10, Kirsten M Fiest3,5,6,7,8,9. 1. Department of Critical Care Medicine, University of Calgary, Calgary, AB, Canada. njaworsk@ucalgary.ca. 2. Alberta Health Services, Calgary, AB, Canada. njaworsk@ucalgary.ca. 3. Department of Critical Care Medicine, University of Calgary, Calgary, AB, Canada. 4. Faculty of Health, Dalhousie University, Halifax, NS, Canada. 5. Alberta Health Services, Calgary, AB, Canada. 6. Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada. 7. O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada. 8. Department of Psychiatry, University of Calgary, Calgary, AB, Canada. 9. Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada. 10. Departments of Pharmacy and Medicine, Leslie Dan Faculty of Pharmacy, Sinai Health System, University of Toronto, Toronto, Canada.
Abstract
BACKGROUND: Antipsychotic medications are frequently prescribed in acute care for clinical indications other than primary psychiatric disorders such as delirium. Unfortunately, they are commonly continued at hospital discharge and at follow-ups thereafter. The objective of this scoping review was to characterize antipsychotic medication prescribing practices, to describe healthcare professional perceptions on antipsychotic prescribing and deprescribing practices, and to report on antipsychotic deprescribing strategies within acute care. METHODS: We searched MEDLINE, EMBASE, PsycINFO, CINAHL, and Web of Science databases from inception date to July 3, 2021 for published primary research studies reporting on antipsychotic medication prescribing and deprescribing practices, and perceptions on those practices within acute care. We included all study designs excluding protocols, editorials, opinion pieces, and systematic or scoping reviews. Two reviewers screened and abstracted data independently and in duplicate. The protocol was registered on Open Science Framework prior to data abstraction (10.17605/OSF.IO/W635Z). RESULTS: Of 4528 studies screened, we included 80 studies. Healthcare professionals across all acute care settings (intensive care, inpatient, emergency department) perceived prescribing haloperidol (n = 36/36, 100%) most frequently, while measured prescribing practices reported common quetiapine prescribing (n = 26/36, 76%). Indications for antipsychotic prescribing were delirium (n = 48/69, 70%) and agitation (n = 20/69, 29%). Quetiapine (n = 18/18, 100%) was most frequently prescribed at hospital discharge. Three studies reported in-hospital antipsychotic deprescribing strategies focused on pharmacist-driven deprescribing authority, handoff tools, and educational sessions. CONCLUSIONS: Perceived antipsychotic prescribing practices differed from measured prescribing practices in acute care settings. Few in-hospital deprescribing strategies were described. Ongoing evaluation of antipsychotic deprescribing strategies are needed to evaluate their efficacy and risk.
BACKGROUND: Antipsychotic medications are frequently prescribed in acute care for clinical indications other than primary psychiatric disorders such as delirium. Unfortunately, they are commonly continued at hospital discharge and at follow-ups thereafter. The objective of this scoping review was to characterize antipsychotic medication prescribing practices, to describe healthcare professional perceptions on antipsychotic prescribing and deprescribing practices, and to report on antipsychotic deprescribing strategies within acute care. METHODS: We searched MEDLINE, EMBASE, PsycINFO, CINAHL, and Web of Science databases from inception date to July 3, 2021 for published primary research studies reporting on antipsychotic medication prescribing and deprescribing practices, and perceptions on those practices within acute care. We included all study designs excluding protocols, editorials, opinion pieces, and systematic or scoping reviews. Two reviewers screened and abstracted data independently and in duplicate. The protocol was registered on Open Science Framework prior to data abstraction (10.17605/OSF.IO/W635Z). RESULTS: Of 4528 studies screened, we included 80 studies. Healthcare professionals across all acute care settings (intensive care, inpatient, emergency department) perceived prescribing haloperidol (n = 36/36, 100%) most frequently, while measured prescribing practices reported common quetiapine prescribing (n = 26/36, 76%). Indications for antipsychotic prescribing were delirium (n = 48/69, 70%) and agitation (n = 20/69, 29%). Quetiapine (n = 18/18, 100%) was most frequently prescribed at hospital discharge. Three studies reported in-hospital antipsychotic deprescribing strategies focused on pharmacist-driven deprescribing authority, handoff tools, and educational sessions. CONCLUSIONS: Perceived antipsychotic prescribing practices differed from measured prescribing practices in acute care settings. Few in-hospital deprescribing strategies were described. Ongoing evaluation of antipsychotic deprescribing strategies are needed to evaluate their efficacy and risk.
Authors: Zoé Thiboutot; Marc M Perreault; David R Williamson; Louise Rose; Sangeeta Mehta; Melanie D Guenette; Deborah Cook; Lisa Burry Journal: Can J Hosp Pharm Date: 2016-04-29
Authors: John W Devlin; Yoanna Skrobik; Céline Gélinas; Dale M Needham; Arjen J C Slooter; Pratik P Pandharipande; Paula L Watson; Gerald L Weinhouse; Mark E Nunnally; Bram Rochwerg; Michele C Balas; Mark van den Boogaard; Karen J Bosma; Nathaniel E Brummel; Gerald Chanques; Linda Denehy; Xavier Drouot; Gilles L Fraser; Jocelyn E Harris; Aaron M Joffe; Michelle E Kho; John P Kress; Julie A Lanphere; Sharon McKinley; Karin J Neufeld; Margaret A Pisani; Jean-Francois Payen; Brenda T Pun; Kathleen A Puntillo; Richard R Riker; Bryce R H Robinson; Yahya Shehabi; Paul M Szumita; Chris Winkelman; John E Centofanti; Carrie Price; Sina Nikayin; Cheryl J Misak; Pamela D Flood; Ken Kiedrowski; Waleed Alhazzani Journal: Crit Care Med Date: 2018-09 Impact factor: 7.598
Authors: Esther S Oh; Dale M Needham; Roozbeh Nikooie; Lisa M Wilson; Allen Zhang; Karen A Robinson; Karin J Neufeld Journal: Ann Intern Med Date: 2019-09-03 Impact factor: 25.391
Authors: Roozbeh Nikooie; Karin J Neufeld; Esther S Oh; Lisa M Wilson; Allen Zhang; Karen A Robinson; Dale M Needham Journal: Ann Intern Med Date: 2019-09-03 Impact factor: 25.391
Authors: Louise Carton; Olivier Cottencin; Maryse Lapeyre-Mestre; Pierre A Geoffroy; Jonathan Favre; Nicolas Simon; Regis Bordet; Benjamin Rolland Journal: Curr Pharm Des Date: 2015 Impact factor: 3.116
Authors: Lisa Burry; Brian Hutton; David R Williamson; Sangeeta Mehta; Neill Kj Adhikari; Wei Cheng; E Wesley Ely; Ingrid Egerod; Dean A Fergusson; Louise Rose Journal: Cochrane Database Syst Rev Date: 2019-09-03
Authors: Marie Sahlberg; Ellen Holm; Gunnar H Gislason; Lars Køber; Christian Torp-Pedersen; Charlotte Andersson Journal: J Am Heart Assoc Date: 2015-09-01 Impact factor: 5.501